SCHEMBL20795891

SCHEMBL20795891

CNC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 5/20 0.36
▸ BMP1 P13497 3/20 0.34
▸ C3AR1 Q16581 1/20 0.34
▸ SIRT6 Q8N6T7 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ SIRT5 Q9NXA8 1/20 0.34
▸ MMP1 P03956 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NMT2 O60551 1/20 0.32
▸ NMT1 P30419 1/20 0.32
▸ NPY4R P50391 2/20 0.32
▸ REN P00797 1/20 0.32
▸ NPY1R P25929 1/20 0.32
▸ NPY2R P49146 1/20 0.32
▸ NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20159819 1.00 FURIN (0.36) FURINBMP1C3AR1SIRT6SIRT1
SCHEMBL23736705 1.00 FURIN (0.36) FURINBMP1C3AR1SIRT6SIRT1
SCHEMBL23236822 0.90 BMP1 (0.36) FURINBMP1C3AR1SIRT6SIRT1
SCHEMBL21788077 0.90 FURIN (0.38) FURINC3AR1SIRT6SIRT1SIRT5
SCHEMBL27352679 0.90 FURIN (0.38) FURINC3AR1SIRT6SIRT1SIRT5
SCHEMBL23393940 0.90 SIRT5 (0.39) FURINC3AR1SIRT5LMNAPOLB
SCHEMBL22045351 0.89 FURIN (0.39) FURINC3AR1SIRT6SIRT1SIRT5
SCHEMBL22351933 0.89 FURIN (0.37) FURINBMP1C3AR1SIRT6SIRT1
SCHEMBL21897483 0.89 FURIN (0.39) FURINBMP1C3AR1SIRT6SIRT1
SCHEMBL17758699 0.89 FURIN (0.37) FURINBMP1C3AR1SIRT6SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135723-A1 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC (US) 2023-05-04 — — US disclosed
US-20200291096-A1 BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF Bicyclerd Limited (GB) 2020-09-17 — — US disclosed
US-10711032-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. (US) 2020-07-14 — — US disclosed
US-20200121803-A1 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. 2020-04-23 — — US disclosed
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 — — WO disclosed
WO-2019046278-A1 PAYLOAD AND LINKER DESIGNS FOR PLATINUM-ACRIDINE ANTICANCER AGENTS AND METHODS THEREOF WAKE FOREST UNIVERSITY (US) 2019-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135723-A1 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES CD99, SLC3A2, CD63 FURIN 4666/4885BMP1 4836/4885C3AR1 2936/4885
US-20200291096-A1 BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF STING1, BID, VIP FURIN 613/4885BMP1 1130/4885C3AR1 40/4885
US-10711032-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 FURIN 2414/4885BMP1 1878/4885C3AR1 783/4885
US-20200121803-A1 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES CD99, SLC3A2, CD63 FURIN 4666/4885BMP1 4836/4885C3AR1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback